NCT04531189View on ClinicalTrials.gov

Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson Disease

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

December 11, 2020

Primary Completion Date

March 25, 2022

Study Completion Date

March 25, 2022

Conditions
Wilson Disease
Trial Locations (6)

33136

Jackson Memorial Hospital Miami Transplant Unit University of Miami Miller School of Medicine, Miami

48109

University of Michigan Michigan Medicine Hepatology Clinic Taubman Center, Ann Arbor

60611

Northwestern University Feinberg School of Medicine, Chicago

69120

Universitätsklinikum Heidelberg, Heidelberg

98105

Seattle Children's Hospital, Seattle

06510

Yale University School of Medicine, New Haven

All Listed Sponsors
lead

Ultragenyx Pharmaceutical Inc

INDUSTRY

NCT04531189 - Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson Disease | Biotech Hunter | Biotech Hunter